Tsai CT - Search Results

1

Optimal anticoagulation in elderly patients with atrial fibrillation: Which drug at which dose?

Liao JN, Chan YH, Kuo L, Tsai CT, Lim SS, Chao TF. Liao JN, et al. Among authors: tsai ct. Kardiol Pol. 2022;80(2):128-136. doi: 10.33963/KP.a2022.0046. Epub 2022 Feb 15. Kardiol Pol. 2022. PMID: 35167115 Free article. Review.

2

Uninterrupted non-vitamin K antagonist oral anticoagulants during implantation of cardiac implantable electronic devices in patients with atrial fibrillation.

Tsai CT, Liao JN, Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Chung FP, Tuan TC, Chen SA. Tsai CT, et al. J Chin Med Assoc. 2019 Apr;82(4):256-259. doi: 10.1097/JCMA.0000000000000050. J Chin Med Assoc. 2019. PMID: 30946706

3

Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.

Tsai CT, Liao JN, Chiang CE, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Chung FP, Chao TF, Lip GYH, Chen SA. Tsai CT, et al. JAMA Netw Open. 2020 Jun 1;3(6):e206424. doi: 10.1001/jamanetworkopen.2020.6424. JAMA Netw Open. 2020. PMID: 32478848 Free PMC article.

4

Non-vitamin K antagonist oral anticoagulants versus warfarin in AF patients ≥ 85 years.

Tsai CT, Liao JN, Chen SJ, Jiang YR, Chen TJ, Chao TF. Tsai CT, et al. Eur J Clin Invest. 2021 Jun;51(6):e13488. doi: 10.1111/eci.13488. Epub 2021 Jan 20. Eur J Clin Invest. 2021. PMID: 33420738

5

Risk of Ischemic Bowel Disease in Patients With Atrial Fibrillation Receiving Warfarin or Non-vitamin K Antagonist Oral Anticoagulants.

Liao JN, Chan YH, Kuo L, Tsai CT, Lim SS, Chao TF. Liao JN, et al. Among authors: tsai ct. Front Cardiovasc Med. 2022 Jul 5;9:874460. doi: 10.3389/fcvm.2022.874460. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35865380 Free PMC article.

6

Incidence and Risk Factors for Pregnancy-Associated Venous Thromboembolism: Are There Differences between East and West?

Tsai CT, Chao TF. Tsai CT, et al. Thromb Haemost. 2023 Sep;123(9):911-912. doi: 10.1055/s-0043-1769736. Epub 2023 Jun 5. Thromb Haemost. 2023. PMID: 37276880 No abstract available.

7

Risk of Incident Atrial Fibrillation and Subsequent Use of Oral Anticoagulants in Patients with Dementia.

Tsai CT, Chan YH, Liao JN, Chen TJ, Lip GYH, Chen SA, Chao TF. Tsai CT, et al. Thromb Haemost. 2024 Mar;124(3):253-262. doi: 10.1055/a-2184-7506. Epub 2023 Sep 30. Thromb Haemost. 2024. PMID: 37776848

8

Which dose of apixaban is suitable for Asian patients with atrial fibrillation who have a serum creatinine < 1.5 mg/dL but an estimated glomerular filtration rate < 50 mL/min?

Tsai CT, Liao JN, Chan YH, Kuo L, Liu CM, Lip GYH, Chao TF. Tsai CT, et al. Int J Cardiol Heart Vasc. 2023 Dec 25;50:101333. doi: 10.1016/j.ijcha.2023.101333. eCollection 2024 Feb. Int J Cardiol Heart Vasc. 2023. PMID: 38419610 Free PMC article.

9

The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis-a nationwide cohort study.

Tsai CT, Chan YH, Liao JN, Chen TJ, Lip GYH, Chen SA, Chao TF. Tsai CT, et al. BMC Med. 2024 Mar 13;22(1):113. doi: 10.1186/s12916-024-03338-7. BMC Med. 2024. PMID: 38475752 Free PMC article.

10

Associations of antithrombotic agent use with clinical outcomes in critically ill patients with troponin I elevation in the absence of acute coronary syndrome.

Tsai CT, Lu YW, Chou RH, Tsai YL, Kuo MR, Guo JY, Lu CT, Kuo CS, Huang PH. Tsai CT, et al. Among authors: tsai yl. PLoS One. 2020 May 21;15(5):e0233178. doi: 10.1371/journal.pone.0233178. eCollection 2020. PLoS One. 2020. PMID: 32437395 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

437 results

Search Page